Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek J Hausenloy

Showing results (1-10 of 366) with videos related to

Pageof 37
Sort By:
European Heart Journal. Acute Cardiovascular Care|September 25, 2013
Conditioning the heart to prevent myocardial reperfusion injury during PPCIDerek J Hausenloy
Current Opinion in Pharmacology|December 17, 2008
Drug discovery possibilities from visfatin cardioprotection?Derek J Hausenloy
Thrombosis and Haemostasis|April 8, 2009
Signalling pathways in ischaemic postconditioningDerek J Hausenloy
Cardiology|August 18, 2009
Urinary trypsin inhibition: cardioprotection via the reperfusion injury salvage kinase pathwayDerek J Hausenloy
Current Pharmaceutical Design|December 29, 2012
Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science)Derek J Hausenloy
Circulation|May 19, 2025
Response by Bulluck and Hausenloy to Letter Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (the PITRI Trial)"Heerajnarain Bulluck, Derek J Hausenloy,
Circulation|April 18, 2018
Letter by Bulluck and Hausenloy Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage"Heerajnarain Bulluck, Derek J Hausenloy
JACC. Cardiovascular Imaging|August 22, 2017
Risk Stratification by Cardiovascular Magnetic Resonance After Reperfused ST-Segment Elevation Myocardial Infarction: Ready for Prime Time?Derek J Hausenloy, Heerajnarain Bulluck
Journal of the American College of Cardiology|April 20, 2019
Translating Cardioprotection for Patient Benefit: The EU-CARDIOPROTECTION COST ActionDerek J Hausenloy, Gerd Heusch
Nature Medicine|September 5, 2018
Modulating NAD<sup>+</sup> metabolism to prevent acute kidney injuryHeerajnarain Bulluck, Derek J Hausenloy
Pageof 37

Showing results (1-10 of 366) with videos related to

Sort By:
Pageof 37
European Heart Journal. Acute Cardiovascular Care|September 25, 2013
Conditioning the heart to prevent myocardial reperfusion injury during PPCIDerek J Hausenloy
Current Opinion in Pharmacology|December 17, 2008
Drug discovery possibilities from visfatin cardioprotection?Derek J Hausenloy
Thrombosis and Haemostasis|April 8, 2009
Signalling pathways in ischaemic postconditioningDerek J Hausenloy
Cardiology|August 18, 2009
Urinary trypsin inhibition: cardioprotection via the reperfusion injury salvage kinase pathwayDerek J Hausenloy
Current Pharmaceutical Design|December 29, 2012
Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science)Derek J Hausenloy
Circulation|May 19, 2025
Response by Bulluck and Hausenloy to Letter Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (the PITRI Trial)"Heerajnarain Bulluck, Derek J Hausenloy,
Circulation|April 18, 2018
Letter by Bulluck and Hausenloy Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage"Heerajnarain Bulluck, Derek J Hausenloy
JACC. Cardiovascular Imaging|August 22, 2017
Risk Stratification by Cardiovascular Magnetic Resonance After Reperfused ST-Segment Elevation Myocardial Infarction: Ready for Prime Time?Derek J Hausenloy, Heerajnarain Bulluck
Journal of the American College of Cardiology|April 20, 2019
Translating Cardioprotection for Patient Benefit: The EU-CARDIOPROTECTION COST ActionDerek J Hausenloy, Gerd Heusch
Nature Medicine|September 5, 2018
Modulating NAD<sup>+</sup> metabolism to prevent acute kidney injuryHeerajnarain Bulluck, Derek J Hausenloy
Pageof 37